Adaptive Medicine 3(2): 73-84, 2011                                                                                       ...
74                                                Tan, Hung and Tsaoconserved amino acid sequence (QKRAA, QRRAA,          ...
Genetic and Environmental Risk Factors in Rheumatoid Arthritis                       75                      Table 1. Conf...
76                                                  Tan, Hung and TsaoCCL21, and BLK exhibiting evidence for associa-     ...
Genetic and Environmental Risk Factors in Rheumatoid Arthritis                        77transduction from IL-2 (55), was v...
78                                                    Tan, Hung and Tsao                                                  ...
Genetic and Environmental Risk Factors in Rheumatoid Arthritis                         79                                 ...
80                                                        Tan, Hung and Tsaogenetic risk factor of RA, has been associated...
Genetic and Environmental Risk Factors in Rheumatoid Arthritis                                               81      epito...
82                                                              Tan, Hung and Tsao    (Oxford). 45: 804-807, 2006.        ...
Genetic and Environmental Risk Factors in Rheumatoid Arthritis                                               83      M.H. ...
84                                                                 Tan, Hung and Tsao       Toes, R.E., de Vries, N., Bego...
Upcoming SlideShare
Loading in …5

73 84


Published on

Published in: Technology, Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

73 84

  1. 1. Adaptive Medicine 3(2): 73-84, 2011 73DOI: 10.4247/AM.2011.ABB005 ReviewRheumatoid Arthritis: An Orchestra of Genetic, Autoimmuneand Environmental FactorsWenfeng Tan 1, Weiting Hung 2, and Betty P. Tsao 11 Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA2 Division of Allergy, Immunology and Rheumatology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of ChinaClinical presentation of rheumatoid arthritis (RA) may Introductionbe the results of a combination of genetic and environ-mental risk factors resulting in a prominent autoimmune Rheumatoid arthritis (RA) (MIM180300) is the mostcomponent. Evidence from case-control studies, either common inflammatory arthritis affecting 0.5-1% ofusing the candidate gene or genome-wide association populations worldwide, and is approximately 2 to 3approaches, have revealed more than 30 loci that are as-sociated with RA susceptibility. Many RA-associated times higher in women than men. RA is characterizedgene variants are involved in pathways of T-cell, B-cell by inflammatory polyarthritis, destruction of cartilageand NF-κB signaling. HLA-DRB1 shared epitope is a and underlying bone as well as the presence of autoanti-major determinant of genetic predisposition to RA de- bodies (rheumatoid factor [RF] and antibodies to cyclicvelopment in different ethnic groups, which is involved citrullinated peptide [ACPA]). Although the etiologyin T-cell antigen presentation and the production of is not fully understood, the puzzle of RA pathogenesisanti-cyclic citrullinated peptides antibodies (ACPA). is slowly fitting together during the past decades. It isThe presence or absence of ACPA appears to stratify RA known that a combination of genetic and environmen-patients into two distinct subsets with different genetic tal risk factors contributes to breaching of the immuneprofiles, clinical courses and histological findings. Inaddition to the shared epitope, a growing number of tolerance, leading to autoimmune manifestations ofgene variants is associated with RA in multiple ethnic RA (25,103). In this article, we will outline the keygroups, including STAT4, AFF3, CCR6, CCL21, and findings regarding the pathogenesis of RA, focusingBLK. Some of the RA-associated gene variants may be on the interactions between genetic, autoimmunity andparticularly important in a specific ethnic group; for environment in the development of RA.example, PTPN22 in populations of European ancestryand PADI4 in Asians. Emerging evidence has shown Genetic Risk in RAthat many disease-associated loci are shared amongmultiple autoimmune diseases, including type 1 diabetes, Major Histocompatibility Complex (MHC)-Regionsystemic lupus erythematosus, inflammatory bowel diseaseand multiple sclerosis, suggesting the presence of commonpathways in the pathophysiology of these diseases. In Cumulative evidence from the twin studies (70), familyaddition to genetic risk factors, recent data have impli- studies (2, 48), and genome-wide linkage scans (31,cated cigarette smoking and infection of P. ginivitis as 49, 58, 95, 97-99, 102, 113) has strongly indicatedenvironmental risk factors that may potentiate disease that genetic contribution to RA susceptibility. Therisk in genetically susceptible individuals. Frequent most robust risk factor that has been reproduciblyand long-term exposure to insecticides also may increase identified in multiple populations is HLA-DRB1 vari-risks for RA development. Further studies to understand ants located in the short arm of chromosome 6 (6p21.3)functional consequences of disease-associated gene vari- encoding the MHC class II molecules.ants and gene-environment interactions that impact onthe immune system are likely to lead to the development A genetic link between HLA-DR and RA wasof novel therapies and/or prevention strategies for RA. initially described in the 1970s, showing HLA-DR4 occurred in 70% of RA patients but only present inKey Words: genetic epidemiology, GWAS, autoimmune, 30% of controls (103). In the 1980s, Gregersen et smoking, periodontal disease, rheumatoid al. proposed the ‘shared epitope’ hypothesis (32). arthritis According to this hypothesis, individuals who share aCorresponding author: Betty P. Tsao, Ph.D., Division of Rheumatology, Department of Medicine, Rehabilitation Center, Room 32-59, 1000Veteran Avenue, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095-1670, USA. Tel: +1-310-825-8906, Fax: +1-310-825-6903, E-mail: Btsao@mednet.ucla.eduReceived: April 22, 2011; Revised: May 28, 2011; Accepted: June 10, 2011.2011 by The Society of Adaptive Science in Taiwan and Airiti Press Inc. ISSN : 2076-944X.
  2. 2. 74 Tan, Hung and Tsaoconserved amino acid sequence (QKRAA, QRRAA, position 1856 of this gene (rs2476601 [(R620W)])or RRRAA) at positions 70-74 in the third hyper- leads to substitution of tryptophan (W) for argininevariable region of the DRB1 chain show an increased (R) at residue 620 of the protein product, resulting inrisk for disease. Subsequently, numerous studies increased risk of RA by 40-80% in Caucasians (40,have confirmed the association between RA and allelic 41). However, this genetic association has not beenvariants at HLA-DRB1 including HLA-DRB1 *04 allele found in Asian populations (7, 65, 113). Interestingly,group (e.g. *04:01, *04:04, *04:05 and *04:08), HLA- PADI4, a member of peptidyl arginine deiminasesDRB1 *01:01 or *01:02, HLA-DRB1*14:02 and HLA- family genes encoding enzymes that are responsibleDRB1*10:01 (46). The risk alleles with the greatest for the post-translational modification of arginine toassociation with RA are *04:01, *04:04, *01:01, and citrullin, has been consistently associated in Asian*14:02. The HLA-DRB1 may also predict the earlier populations (23, 47, 51), but has yielded conflictingage of RA onset and more severe disease. RA patients association results in Caucasian populations (13, 27,who carry two copies of risk alleles tend to have a 104).greater prevalence of extra-articular disease and bone The strikingly feature after 2007 is that unprece-erosions than patients who carry a single copy of the dented international collaborations, large patientrisk allele (16, 29). More recently, studies have collections as well as growing genome-wide associa-shown that HLA-DRB1 shared epitope alleles only tion studies, have made genetic study a revolution. Ainfluence the development of seropositive RA, and large-scale genetic association study has identifiedmore specifically for ACPA positive RA (45, 57). the risk allele in STAT4 (rs7574865) is common in The MHC region spans 3.6 megabases (Mb) and individuals of Asian, African, and European ances-contains a wide range of other immunologically re- tries (1624 cases and 2635 controls), providing alevant genes. Several candidate genes within the MHC significant contribution to RA susceptibility (40).have been implicated contributing to the susceptibility Subsequently, a similar strong association signal ofof RA, including MHC I chain related gene A (MICA) this SNP has been replicated in another large case-(56), the MHC class II gene HLA-DQB1*03:01 (81), control study of the British population (6400 casesthe MHC class III genes tumor necrosis factor alpha and 6422 controls) (5).(TNFA) and nuclear factor inhibitor of kappa B-like To date, 5 genome-wide association studies in(NFKBIL1) (54). However, these genes have not been RA have been performed, uncovering many new genescomprehensively tested in large case-control popula- or loci associated robustly with susceptibility for RAtions, and conflicting reports in different ethnicities (26, 49, 87, 102, 113). The landmark study of GWASmake them inconclusive (67, 75). Thus, it will need is reported by Trust Case Control Consortium (WTCCC),further work to provide additional insight into these which performed an genome-wide analysis on 7MHC genes. common diseases including RA in the UK population (113). In this study, the two well-known genes, HLA-Non-MHC Genes DRB1 and PTPN22, and nine additional variants were identified for association with RA. The replicationHLA-DRB1 gene has been estimated accounts for study was performed in a large independent UK cohortapproximately one-third of the overall genetic com- (5063 cases and 3849 controls) by genotyping theseponent of RA risk (34). There are approximately 10 9 variants resulting in the discovery of a novel RAmillion common single-nucleotide polymorphisms risk locus, TNFAIP3 at 6q23 (rs6920220) (109).(SNPs) in the human genome, which makes the identi- Subsequently, many additional RA-associated genesfication of RA susceptibility genes that lie outside the were revealed by GWAS including TRAF1-C5, REL,MHC region more challenging. After the discovery of CTLA4, BLK, KLF12, CCR6, CD40, CD28, PRDM1,HLA associations, a long period of genetic investi- CD2/CD58, L6ST, SPRED2, RBPJ, IRF5, PXK,gation during the 1990s and early 2000s has yielded C5orf30, UBE2L3, TAGAP, SH2B3, 8q24.2, DDX6,evidence for additional genetic regions linked to RA CD247 and UBASH3A (17, 31, 49, 58, 85, 98, 99,susceptibility; however, with a few exceptions, no de- 102, 121). Interestingly, the previously identifiedfinitive risk alleles have been identified. Advances in RA-susceptibility R620W PTPN22 allele has beenhuman genetics, especially the substantial progress in replicated in almost all GWAS using Europeangenome-wide association study (GWAS), have greatly populations, highlighting its pivotal role in the RApromoted the discovery and independent replication pathogenesis, especially in European populations.of a growing number of RA-associated gene variants. As of April, 2011, more than 30 new non-HLA One of the most convincing non-HLA loci as- loci contributing to RA have been discovered andsociated with RA is PTPN22, a negative regulator of confirmed (Table 1). The latest GWAS study inT-cell activation on chromosome 1, identified in 2004 Koreans found that a number of the established(7). A missense C-to-T substitution at nucleotide Caucasian risk loci, including, STAT4, AFF3, CCR6,
  3. 3. Genetic and Environmental Risk Factors in Rheumatoid Arthritis 75 Table 1. Confirmed non-HLA loci associated with RA susceptibilityGene Location SNP OR Population ReferencePADI4 1p36 rs2240340 1.4 Japanese Suzuki 2003 (104)PTPN22 1p13 rs2476601 1.65 North American Begovich 2004 (7)CTLA4 2q33 rs3087243 1.14 Swedish, North American Plenge 2005 (96)FCRL3 1q23 rs7528684 2.15 Japanese Kochi 2005 (59)TNFAIP 6q23 rs6920220 1.33 UK Thomson 2007 (109) rs10499194 1.22 North America (BRASS), Swedish Plenge 2007 (95) rs5029937 1.34 UK Orozco 2009 (86) rs1953126 1.1 European Zhernakova 2011 (121)STAT4 2q32 rs7574865 1.32 North American Remmers 2007 (100) Zhernakova 2011 (121)IL2/IL21 4q27 rs6822844 1.39 Dutch Zhernakova 2007 (120)TRAF1/C5 9q33 rs3761847 1.32 Swedish, North American Plenge 2007 (97) rs7021049 1.39 Dutch, North American Chang 2008 (15) rs10760130 1.09 UK Barton 2008 (5) rs10818488 1.28 Dutch, Swedish, North American Kurreeman 2007 (61) rs1953126 1.1 European Zhernakova 2011 (121)CD40 20q13 rs4810485 0.91 UK, Dutch, Swedish, North American Raychaudhuri 2008 (98)TNFSF30 1p36.2 rs3890745 0.92 UK, Dutch, Swedish, North American Raychaudhuri 2008 (98)CCL21 9p13 rs2812378 1.1 UK, Dutch, Swedish, North American Raychaudhuri 2008 (98)PRKCQ 10p15 rs4750316 0.86 UK, Dutch, Swedish, North American Raychaudhuri 2008 (98) Barton 2008 (6)MMEL1 1p36 rs3890745 0.86 UK, Dutch, Swedish, North American Raychaudhuri 2008 (98)KIF5A 12q13 rs1678542 0.92 UK, Dutch, Swedish, North American Raychaudhuri 2008 (98) Barton 2008 (6)CDK6 7q21 rs42041 1.15 UK, Dutch, Swedish, North American Raychaudhuri 2008 (98)IL2RB 22q13 rs3218253 1.11 UK, Dutch, Swedish, North American Barton 2008 (6)CD244 1q23 rs3766379 1.37 Japanese Suzuki 2008 (105) rs6682654 1.34 Japanese Suzuki 2008 (105)CD28 2q33 rs1980422 1.13 European and North American Raychaudhuri 2009 (99)PRDM1 6q rs548234 1.11 European and North American Raychaudhuri 2009 (99)CD2/CD58 2q33 rs11586238 1.13 European and North American Raychaudhuri 2009 (99)REL 2p16 rs13031237 1.21 North American Gregersen 2009 (31)AFF3 2q11 rs10865035 1.12 UK Barton 2009 (4)SPRED2 2p30 rs934734 1.13 European Stahl 2010 (102)ANKRD55 5q11 rs6859219 0.78 European Stahl 2010 (102)C5orf30 5q21 rs262321 0.88 European Stahl 2010 (102)PXK 3p14 rs13315591 1.29 European Stahl 2010 (102)RBPJ 4p15 rs874040 1.14 European Stahl 2010 (102)CCR6 6q27 rs3093023 1.13 European Stahl 2010 (102) rs3093024 1.19 Japanese Kochi 2010 (58)IRF5 7q32 rs10488631 1.19 European Stahl 2010 (102)BLK 8p22 rs2736340 1.14 European Orozco 2011 (85)UBE2L3 22q11 rs5754217 1.14 European Orozco 2011 (85) rs2298428 1.11 European Zhernakova 2011 (121)TAGAP 6q25 rs212389 0.87 European Chen 2011 (17)SH2B3 12q24 rs653178 1.07 European Zhernakova 2011 (121)8q24.2 8q24 rs975730 0.93 European Zhernakova 2011 (121)DDX6 11q23 rs10892279 0.87 European Zhernakova 2011 (121)CD247 1q24 rs864537 0.9 European Zhernakova 2011 (121)UBASH3A 21q22 rs11203203 1.11 European Zhernakova 2011 (121)
  4. 4. 76 Tan, Hung and TsaoCCL21, and BLK exhibiting evidence for associa- neutrophils and synovial fibroblasts play central rolestion (26). They also discovered 10 novel loci in the pathogenesis of joint inflammation and disease(rs1600249, rs2736340 in BLK; rs2009094 in AFF3; progression in RA. The strong genetic association ofrs12831974 in TRHDE; rs7024727 in CCL21; HLA-DR and RA implies that the disease is, at leastrs657555 in PTPN2; rs2062583 in ARHGEF3; in part, driven by T cells. Studies from crystal structurers7537965 in GPR137B; rs4867947 in LCP2/C5orf; of HLA-DR molecules showed that the RA-associatedrs4547623 in GGA1/LGALS2; rs4936059 in FLI1/ QKRAA region primarily faces away from the antigen-ETS1) associated with RA susceptibility. However, binding cleft of the DR molecule. Citrullination ofnone of these associations reach genome-wide peptides triggers a stronger immune response in humansignificance (P = 5 × 10 -8). It is estimated that these HLA-DR4 transgenic mice via increasing the affinityknown non-MHC risk alleles contribute between 3- to HLA-DR molecule and activating CD4+ T cells5% of the genetic burden of RA (102) suggesting (39), suggesting HLA-DR molecules were involvedadditional risk alleles remain to be identified. It is in antigen presentation. Accordingly, prevailing hy-clear that the development of RA is dependent on potheses postulate that specific HLA-DR alleles conferinputs from multiple loci. susceptibility to RA through 1) their involvement in Given that the relative risks for these common presenting arthritogenic self-peptides to CD4+ T cellvariants are generally modest, it is hypothesized that (110), 2) molecular mimicry with foreign Ags (48),rare genetic variants (with population frequency <1%) and/or 3) T cell repertoire selection (98). In additionand/or copy number variants (CNV) may be the major to antigen presentation, most recent studies suggestedcontributors to disease susceptibility (1, 35). Uddin that the SE functions as an allele-specific signal-et al. reported genome-wide CNV burden is 2-fold transducing ligand that can polarize T cell differentia-higher in patients with RA compared with controls tion toward Th17 cells, facilitating autoimmunity in(114). They identified rare copy number variable mice (20).regions including TNFAIP3, TNIP1, IRF1, ALOX5AP, In additional to class II MHC region, risk allelesLCP2, B2M and PRKCH by using the WTCCC high- highlight genes involved in T cell activation by antigendensity SNP genotype data. The challenge now is to presenting cells including PTPN22, STAT4, IL2/IL21,identify the remaining, genetic effects and their func- IL2RB, CD28, and CTLA4. A missense C-to-T sub-tional roles of these RA-associated variants in the stitution at nucleotide position 1856 of PTPN22 leadspathogenesis of RA, and to explore how they interact to substitution of tryptophan (W) for arginine (R) atwith each other as well as environmental factors to in- residue 620 of the protein product, resulting in en-duce the development of RA. hanced regulation of T-cell receptor (TCR) signaling In summary, the most convincing evidence for during thymic selection, permits autoantigen-specificRA association is the HLA-DRB1 alleles expressing T cells to escape clonal deletion. STAT4, a signalthe share epitope, which has been consistently de- transducer and activator of transcription 4, encodesmonstrated in ethnically diverse populations (26, 31, a transcription factor that transduces interleukin-1249, 58, 95, 97-99, 102, 113). STAT4, CCR6, AFF3, (IL-12), interleukin-23 (IL-23), and type I interferonCCL21 and BLK are also important genetic risk factors cytokine signals in T cells and monocytes, leadingin Asians, European and African derived populations to T-helper type 1 (Th1) and T-helper type 17 (Th17)(26, 31, 58, 100, 121). PADI4, FCRL3 and CD244 are differentiation, and production of interferon-γ (73,specific risk factors in Asian populations (59, 104, 82), suggesting the critical role in the development of105) while TNFSF14, MMEL1, CDK6, PRKCQ, a Th1 and Th17 type T-cell response. STAT4-deficientKIF5A, SPRED2, ANKRD55, PTPN22, TNFAIP3, mice are generally resistant to models of autoimmuneTRAF1-C5, CTLA4, REL, CD40, CD28, PRDM1, CD2/ disease, including arthritis (24), highlighting its roleCD58, C5orf30, PXK, RBPJ, IRF5, UBE2L3, TAGAP, in RA pathogenesis. Although previous studies didSH2B3, 8q24.2, DDX6, CD247, UBASH3A, IL2/IL21, not find an allele-specific role of STAT4 in gene ex-IL2RB, AFF3, are shown to be significantly associated pression, it is quite possible that variants located inwith RA in European-derived populations (5, 7, 17, STAT4 introns could influence its gene transcription31, 61, 85, 87, 95, 97-99, 102, 109, 121). Taken rate of its alternatively spliced forms by altering atogether, it is important to consider ethnic differences transcription factor binding site or a binding site forin RA genetic predisposition. modified histone proteins (60). Recent associations have also clearly implicatedGenetic Risk in Immune Pathways the interleukin-2 (IL-2) signaling pathway, a critical cytokine involved in T cell activation and proliferation.T Cell Pathways The IL2RB, encodes the beta unit of the interleukin- 2 receptor (IL2R) present in the moderate and highIt is well established that T cells, B cells, macrophages, affinity forms of the receptor required for signal
  5. 5. Genetic and Environmental Risk Factors in Rheumatoid Arthritis 77transduction from IL-2 (55), was validated for genetic address the role of IL-23 variants in RA susceptibility.association with RA in European ancestries (6). Theimplicated SNP of the IL2/IL21 locus was associated B Cell Pathwayswith RA and type 1 diabetes, supporting a general risklocus for multiple autoimmune diseases (120). Func- B cells have long been considered playing an importanttional connections between IL2/IL21 and IL2RB loci role in RA since the discovery of autoantibody in se-are clearly highlighted genetic factor involved in rum samples from RA patients. Several autoantibodiesIL-2 signaling pathway. have been described in RA. Among them, RF exhibits T cells activation derived from naïve T cell upon 70-80% sensitivity and has been widely used in clinicalinteraction of the TCR with specific peptides presented settings traditionally. ACPA, which is more specificby MHC molecules are regulated by a delicate balance for RA compared to RF, can be detected years beforebetween costimulatory signals that activate T cells, the first clinical manifestations and is associated withand inhibitory signals that attenuate harmful inflam- a more severe, erosive arthritis compared to ACPAmatory responses (19). Simultaneous recognition of negative RA patients, implying a putative role as athe cognate MHC-peptide complex by the TCR (signal predictor for the development of RA. Though citrul-1) and B7 costimulatory family members (CD80/ linated peptides are present in the rheumatoid syn-CD86) by CD28 (signal 2) results in T cell activation, ovium, suggesting a possible pathogenic role of thisproliferation, and differentiation. The association autoantibody (51), there are no direct evidence forbetween variants with costimulatory receptors CD28 their contribution to the pathogenesis of RA. HLA-(99) and its inhibitory receptors CTLA4 (96) predispos- DRB1, PTPN22, TRAF1–C5, CD40, FCGR3A, STAT4,ing to RA highlighted the critical role of costimulatory REL and PADI4 have been identified and validated inpathways in RA pathogenesis. ACPA positive RA patients (14, 97, 100, 106, 108, A newly identified subset of CD4 effector T 116). However, none of these loci achieved genome-helper that produces interleukin-17 (IL-17), termed wide significant in ACPA negative RA patients. Re-Th17 cells, have been implicated as the pivotal driving cently, one GWAS study in Sweden found that oneforce of autoimmune inflammation in collagen or SNP close to the RPS12P4 locus in chromosome 2adjuvant-induced arthritis (28, 63, 78). In RA, clinical might be considered as a candidate locus for APCAdata suggested that IL-17 is mainly involved in the negative RA (87). SE+ RA patients with co-occurrenceprogression of joint damage (115) and might be a of ACPA positive at baseline had a significantly higherfuture therapeutic target for RA. Polymorphism in rate of joint destruction than did other RA patientsCCR6 (rs3093024), the gene encoding chemokine (117). Intriguingly, the histology study demonstrated(C-C motif) receptor 6 (a surface marker for Th17 that ACPA positive synoviums appeared to be char-cells), was identified and validated with RA susce- acterized by denser lymphocyte infiltrations and aptibility in Japanese (58) and Caucasians (102). In- higher rate of joint destruction, whereas more exten-terestingly, a triallelic dinucleotide polymorphism of sive fibrotic changes were apparent in ACPA negativeCCR6 (CCR6DNP) in strong linkage disequilibrium tissue (98). Taken together, RA is probably a clinicalwith rs3093024 that could affect levels of CCR6 tran- syndrome consisting of at least two distinct diseasescription, was associated with the levels of IL-17 in subsets defined by the presence or absence of ACPA.serum samples of RA patients, suggesting that CCR6 FCRL3 is a member of the Fc receptor-likeis critically involved in IL-17 driven autoimmunity family and its precise function of FCRL3 is unknown.(58). In the development of Th17 cells, IL-23 plays A RA-associated FCRL3 promoter SNP could altersan important role in cells expansion and maintenance the binding affinity of NF-κB and FCRL3. Inter-(89). Case-control studies in 3 Caucasian cohorts and estingly, RA patients carrying the FCRL3 risk allele1 Korean cohort have been conducted to investigate conferred higher FCRL3 expression on B cell surfacesthe association of IL-23 receptor (IL-23R) poly- and augmented autoantibody production comparedmorphism and RA susceptibility (42, 90, 113, 118). with non-carriers, suggesting that FCRL3 might in-However, these studies yielded either no evidence fluence the fate of B cells and augment the emergencefor association or identified SNPs of one study that of self-reactive B cells in RA patients.were not evaluated in other independent panels. Thisapparent discrepancy may due to different candidate NF-κB Signaling PathwaySNPs genotyped in each study, inadequate power todetect association, and ethnic variations in allele The NF-κB family, consists of p50 (NF-κB1), p52frequencies and linkage disequilibrium patterns. (NF-κB2), p65 (RelA), RELB, and REL (c-Rel). UponTherefore, further studies are needed to evaluate a to stimuli, a dimer of NF-κB proteins acts as a tran-comprehensive set of informative markers of IL-23R scription factor binds to a κB site in the promoter orin large collections of RA case-control panels to enhancer of a target gene, controlling immune re-
  6. 6. 78 Tan, Hung and Tsao IL2/21 IL2RB STAT4 CCR6 B7-CD28 Th1/Th17 differentiation CD28 MHCII-TCR HLA-DRB1 T cell activation PTPN22 B7-CTLA4 CTLA4 NFκB activation CD40 PRKCQ TNFAIP3 TRAF1 TNFRSF14 REL APC T cell PADI4 PTPN22 HLA-DRB1 FCGR3A REL TRAF1-C5 STAT4 CD40 B cell Autoantibody ACPA positive Fig. 1. Gene loci associated with RA susceptibility and their potential roles in RA pathogenesis.sponses and autoimmunity (36). Several RA risk loci pathophysiological pathways other than those current-containing genes that are involved in NF-κB signal- ly known. Much more work remains before a completeing, including CD40, TRAF1, TNFAIP3, PRKCQ, understanding in the function of the causal variantsTNFRSF14 and the recent report of REL. CD40, ex- and their roles in autoimmune pathway of RA ispressed on the cell surfaces of APCs, is a TNF receptor needed for the eventual improvement of patient member (TNFRSF5). This receptor is essentialin mediating a variety of B-cell responses, including Interaction of Genetic, Immunity andB-cell proliferation and differentiation, with predom- Environment Factorinant activation through NF-κB pathways (76). Acommon variant at the CD40 locus showed very strong Although several potential environmental factors haveevidence for association with RA (P = 8.2 × 10 -9) in been linked to RA susceptibility or disease severitya large GWAS meta-analysis study, including a total including coffee consumption, in particular decaf-of >7300 autoantibody positive RA cases and >18000 feinated coffee, cigarette smoking history, exposurematched control individuals (97). REL, encoding c- to air pollution, and environmental exposure to silica-Rel, have recently identified as a new risk locus for containing dust (21). To date, smoking and periodon-rheumatoid arthritis (31). A variety of genes in T cells titis are the mostly well-established environmentalare regulated by c-Rel, including CD40 and other ac- risk factors.cepted RA susceptibility loci TNFAIP3 (95), sug- The role for smoking is first reported more thangesting an important role of CD40/NF-κB signaling 15 years ago, and its role in RA has been highlightedpathways in RA pathogenesis. recently by new evidence of interactions among smok- Recent genetic discoveries have indentified ing, the presence of shared epitope, and the presencemany RA risk loci involved in autoimmune and in- of ACPA (38). The landmark study of gene-environ-flammatory pathways (Fig. 1). Thus, it is not surpris- ment interaction was described by Klareskog anding that many of these loci predispose to more than colleagues (57, 88). This work demonstrated thatone autoimmune diseases including type 1 diabetes patients with RA onset within the previous year, smokers(T1D), systemic lupus erythematosus (SLE), inflam- without HLA-DRB1*SE alleles (SE negative) werematory bowel disease, and multiple sclerosis in 1.5 times more likely to develop ACPA positive RAaddition to RA (6, 46, 77, 94, 100), suggesting shared compared to SE negative nonsmokers. The risk ofautoimmune pathways affected by genes and en- developing ACPA positive RA is increased 21-fold invironment factors. On the other hand, physiological individuals who have smoking history and the pres-functions of some associated genes, such as ANKRD55 ence of double copies of HLA-DR SE compared toand C5orf30, are not clear yet, suggesting additional SE-negative nonsmokers (57). Subsequently, this
  7. 7. Genetic and Environmental Risk Factors in Rheumatoid Arthritis 79 AT HLA-DRB1 CG CG Genetic PTPN22 AT Smoking TA nt CG CG me CG on vir En Autoimmunity Autoantigen- Citrullination production RA Fig. 2. Schematic diagram of the interaction between genetic, immune and environment factors.interaction was confirmed in three large case-control autoantigens in the lungs; thus, immune activationstudies: the Swedish Epidemiological Investigation against such posttranslationally modified proteinsof Rheumatoid Arthritis (EIRA) study, the North would be preferentially induced in individuals carryingAmerican RA Consortium (NARAC) study, and the HLA-DRB1 SE alleles (50) (Fig. 2).Dutch Leiden Early Arthritis Clinic study (in total, Another interesting environmental risk factor in1,977 cases and 2,405 controls) (50). Interestingly, the pathogenesis of RA is periodontitis. The preva-although no interaction is seen between smoking and lence and severity of periodontitis is increased in RAPTPN22, combinations of HLA-DRB1, PTPN22 and (18, 33, 37, 93) and this phenomenon cannot be at-smoking confer a high odds ratio (OR = 23-25) to the tributed to secondary Sjögren syndrome (37, 62, 92).development ACPA positive RA, highlighting that MHC On the other hand, RA disease severity, includingclass II-dependent T-cell activation is of central numbers of swollen joints, serum C-reactive proteinpathogenic importance for the subset of ACPA positive levels and erythrocyte sedimentation rate are as-RA (50). A study using three large US cohorts (64) sociated with the severity of periodontitis (74). Therefailed to demonstrate the interaction among ever is also a significant correlation between the presencesmoking, SE-positivity, and the presence of ACPA in of ACPA and the presence of periodontitis in RA pa-RA patients. However, another prospective case-control tients (79). There is a link in important inflammatorystudy in US observed strong smoking-SE interaction cytokines between RA and periodontitis. Elevatedby stratifying pack-year rather than by ever (52). These serum levels of TNF, IL-1 and IL-17 are correlatedresults suggest that smoking has a cumulative effect with the degree of tissue destruction in periodontitison RA development in SE-positive individuals. (30, 112, 119). Evidence also showed that RANK- Recently, antibodies to the immunodominant RANKL plays an important role in inducing alveolarcitrullinated α-enolase CEP-1 epitope, a subset of the bone loss in aggressive periodontitis (8, 11, 12, 68,ACPA response with specific autoimmunity to citrul- 105, 107, 110), which is also a crucial mechanism inlinated α-enolase, were detected in 43-63% of the RA bone erosion.ACPA positive RA patients. In a 1,000 case- 872 con- Emerging data has revealed DNA of Porphy-trol analysis, HLA-DRB1-SE, PTPN22 and smoking romonas gingivalis, the major bacterial cause of peri-showed the strongest association with the anti-CEP- odontitis, is often found in gingiva from gingivalis1–positive subset (OR = 37, compared to OR = 2 for patients (9) and synovium from RA patients (72). P.the corresponding anti-CEP-1–negative, anti-CCP– gingivitis could induce citrullination of human fibrin-positive subset). These results imply that citrullinated- ogen and α-enolase by endogeouns peptidylaginineenolase is a specific citrullinated autoantigen which deiminase (111) which may also lead to the citrullina-links smoking to genetic risk factors in the develop- tion of fibrin in the synovium (66). Presence of gp-ment of RA (71). The possible explanation for the 39, cartilage antigen targeted by the autoimmunestrong interaction between smoking, HLA-DRB1 and response in rheumatoid synovitis, was also found inACPA is that long-term exposure to cigarette to- gingival tissue from periodontitis patients (80).bacco would accelerate the presence of citrullinated Interestingly, HLA-DRB1, the most relevant
  8. 8. 80 Tan, Hung and Tsaogenetic risk factor of RA, has been associated with 2. Bali, D., Gourley, S., Kostyu, D.D., Goel, N., Bruce, I., Bell, A.,development of severe and rapidly progressive peri- Walker, D.J., Tran, K., Zhu, D.K., Costello, T.J., Amos, C.I. and Seldin, M.F. Genetic analysis of multiplex rheumatoid arthritisodontal disease (10). Therefore, the production of families. Genes Immun. 1: 28-36, in gingival and synovium may predis- 3. Bartold, P.M., Marino, V., Cantley, M. and Haynes, D.R. Effect ofpose to the loss of tolerance in susceptible individuals. Porphyromonas gingivalis-induced inflammation on the develop-Furthermore, animal studies showed that introducing ment of rheumatoid arthritis. J. Clin. Periodontol. 37: 405-411, 2010.heat-killed P. gingivalis in rats could accelerate the 4. Barton, A., Eyre, S., Ke, X., Hinks, A., Bowes, J., Flynn, E., Martin,occurrence of adjuvant-induced arthritis (3). However, P., YEAR Consortium, BIRAC Consortium, Wilson, A.G., Morgan,it is unclear at present whether the presence of P. A.W., Emery, P., Steer, S., Hocking, L.J., Reid, D.M., Harrison, P.,gingivalis DNA in the synovium is an epiphenomenon Wordsworth, P., Thomson, W. and Worthington, J. Identificationrelated to DNA trapping by the synovial filter, and of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-whether there is a causal relation between P. gingivalis autoimmune susceptibility genes. Hum. Mol. Genet. 18: 2518-and ACPA production. 2522, 2009. Another possible environmental risk factor of 5. Barton, A., Thomson, W., Ke, X., Eyre, S., Hinks, A., Bowes, J.,RA is insecticide usage. Early studies have shown Gibbons, L., Plant, D., Wellcome Trust Case Control Consortium, Wilson, A.G., Marinou, I., Morgan, A., Emery, P., YEAR consortium,association between farming and RA in men (83, 84) Steer, S., Hocking, L., Reid, D.M., Wordsworth, P., Harrison, P. andthat active components of insecticides and/or their Worthington, J. Re-evaluation of putative rheumtoid arthritisinteraction with other environmental agents (including susceptibility genes in the post-genome wide assocition study eramicrobial products) may affect the immune system and hypothesis of a key pathway underlying susceptibility. Hum. Mol. Genet. 17: 2274-2279, 2008.(22, 44, 69). However, specific environmental triggers 6. Barton, A., Thomson, W., Ke, X., Eyre, S., Hinks, A., Bowes, J.,for RA are yet to be identified (83, 84). Recently, one Plant, D., Gibbons, L.J., Wellcome Trust Case Control Consortium,observational study shows the hazard ratio of RA in- YEAR Consortium, BIRAC Consortium, Wilson, A.G., Bax, D.E.,cidence increased in post-menopausal women who Morgan, A.W., Emery, P., Steer, S., Hocking, L., Reid, D.M.,were exposed to greater frequency (≥ 6 times per Wordsworth, P., Harrison, P. and Worthington, J. Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 andyear) or greater duration (≥ 20 years) of insecticides 22q13. Nat. Genet. 40: 1156-1159, 2008.(91). These findings suggest a possible interaction 7. Begovich, A.B., Carlton, V.E., Honigberg, L.A., Schrodi, S.J.,between environmental exposure to particular chemi- Chokkalingam, A.P., Alexander, H.C., Ardlie, K.G., Huang, Q.,cals and the risk for RA development, which awaits Smith, A.M., Spoerke, J.M., Conn, M.T., Chang, M., Chang, S.Y.,further replication studies. Saiki, R.K., Catanese, J.J., Leong, D.U., Garcia, V.E., McAllister, L.B., Jeffery, D.A., Lee, A.T., Batliwalla, F., Remmers, E., Criswell, L.A., Seldin, M.F., Kastner, D.L., Amos, C.I., Sninsky, J.J. andConclusion Gregersen, P.K. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associ-Gene-immunity-environment interactions are key ated with rheumatoid arthritis. Am. J. Hum. Genet. 75: 330-337, 2004.features in the development of RA. Inheritance of 8. Belibasakis, G.N., Emingil, G., Saygan, B., Turkoglu, O., Atilla, G.multiple gene variants involved in T-cell, B-cell, and and Bostanci, N. Gene expression of transcription factor NFATc1NF-κB signaling pathways predisposes an individual in periodontal diseases. A.P.M.I.S. 119: 167-172, have broken immune tolerance upon environmental 9. Berglundh, T. and Donatim, M. Aspects of adaptive host responsetriggers, leading to the development of RA. To date, in periodontitis. J. Clin. Periodontol. 32: 87-107, 2005. 10. Bonfil, J.J., Dillier, F.L., Mercier, P., Reviron, D., Foti, B., Sambuc,a growing number of gene variants have been identified R., Brodeur, J.M. and Sedarat, C. A case control study on the rolepredisposing to RA in multiple ethnic groups including of HLADR4 in severe periodontitis and rapidly progressive peri-HLA-DRB1, STAT4, TNFAIP3, CCR6, TRAF1, and odontitis. J. Clin. Periodontol. 26: 77-84, 1999.BLK. Patients carrying the HLA-DRB1 shared epitope 11. Bostanci, N., Ilgenli, T. and Emingil, G. Gingival crevicular fluidmay be more vulnerable to environmental factors, in- levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J. Clin. Periodontol. 34: 367-369, 2007.cluding smoking and periodontitis. The identification 12. Bostanci, N., Ilgenli, T., Emingil, G., Afacan, B., Han, B., Töz, H.,of environmental factors that modify disease risk may Berdeli, A., Atilla, G., McKay, I.J., Hughes, F.J. and Belibasakis,impact on risk reduction in disease susceptibility as G.N. Differential expression of receptor activator of nuclear factor-well as in modulating the clinical course of the disease. κB ligand and osteoprotegerin mRNA in periodontal diseases. J. Periodontol. Res. 42: 287-293, 2007.Understand functional consequences of disease-as- 13. Burr, M.L., Naseem, H., Hinks, A., Eyre, S., Gibbons, L.J., Bowes,sociated gene variants and gene-immunity-environ- J., Wilson, A.G., Maxwell, J., Morgan, A.W., Emery, P., Steer, S.,ment interactions are likely to lead to the development Hocking, L., Reid, D.M., Wordsworth, P., Harrison, P., Thomson,of novel therapies and/or prevention strategies for RA. W., Worthington, J., BIRAC Consortium, YEAR Consortium and Barton, A. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann. Rheum. Dis.References 69: 666-670, 2010. 14. Cha, S., Choi, C.B., Han, T.U., Kang, C.P., Kang, C. and Bae, S.C. 1. Altshuler, D., Daly, M.J. and Lander, E.S. Genetic mapping in Association of anti-cyclic citrullinated peptide antibody levels with human disease. Science 322: 881-888, 2008. PADI4 haplotypes in early rheumatoid arthritis and with shared
  9. 9. Genetic and Environmental Risk Factors in Rheumatoid Arthritis 81 epitope alleles in very late rheumatoid arthritis. Arthritis Rheum. 31. Gregersen, P.K., Amos, C.I., Lee, A.T., Lu, Y., Remmers, E.F., 56: 1454-1463, 2007. Kastner, D.L., Seldin, M.F., Criswell, L.A., Plenge, R.M., Holers,15. Chang, M., Rowland, C.M., Garcia, V.E., Schrodi, S.J., Catanese, V.M., Mikuls, T.R., Sokka, T., Moreland, L.W., Bridges, S.L. Jr., J.J., van der Helm-van Mil, A.H. Ardlie, K.G., Amos, C.I., Criswell, Xie, G., Begovich, A.B. and Siminovitch, K.A. REL, encoding a L.A., Kastner, D.L., Gregersen, P.K., Kurreeman, F.A., Toes, R.E., member of the NF-κB family of transcription factors, is a newly Huizinga, T.W., Seldin, M.F. and Begovich, A.B. A large-scale defined risk locus for rheumatoid arthritis. Nat. Genet. 41: 820-823, rheumatoid arthritis genetic study identifies association at chromo- 2009. some 9q33.2. PLoS Genet. 4: e1000107, 2008. 32. Gregersen, P.K., Silver, J. and Winchester, R.J. The shared epitope16. Chen, J.J., Mu, H., Jiang, Y., King, M.C., Thomson, G. and hypothesis. An approach to understanding the molecular genetics Criswell, L.A. Clinical usefulness of genetic information for pre- of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30: 1205- dicting radiographic damage in rheumatoid arthritis. J. Rheumatol. 1213, 1987. 29: 2068-2073, 2002. 33. Hamevose-Poulsen, A., Sorensen, L.K., Stoltze, K., Bendtzen, K.17. Chen, R., Stahl, E.A., Kurreeman, F.A., Gregersen, P.K., and Holmstrup, P. Cytokine profiles in peripheral blood and whole Siminovitch, K.A., Worthington, J., Padyukov, L., Raychaudhuri, blood cell cultures associated with aggressive periodontitis, juve- S. and Plenge, R.M. Fine mapping the TAGAP risk locus in nile idiopathic arthritis, and rheumatoid arthritis. J. Periodontol. rheumatoid arthritis. Genes Immun. 2: 314-328, 2011. 76: 2276-2285, 2005.18. Craig, R.G., Boylan, R., Yip, J., Mijares, D., Imam, M., Socransky, 34. Hasstedt, S.J., Clegg, D.O., Ingles, L. and Ward, R.H. HLA-linked S.S., Taubman, M.A. and Haffajee, A.D. Serum IgG antibody rheumatoid arthritis. Am. J. Hum. Genet. 55: 738-746, 1994. response to periodontal pathogens in minority populations: rela- 35. Hastings, P.J., Lupski, J.R., Rosenberg, S.M. and Ira, G. Mecha- tionship to periodontal disease status and progression. J. Periodontal. nisms of change in gene copy number. Nat. Rev. Genet. 10: 551- Res. 37: 132-146, 2002. 564, 2009.19. Crawford, A. and Wherry, E.J. The diversity of costimulatory and 36. Hayden, M.S., West, A.P. and Ghosh, S. NF-κB and the immune inhibitory receptor pathways and the regulation of antiviral T cell response. Oncogene 25: 6758-6780, 2006. responses. Curr. Opin. Immunol. 21: 179-186, 2009. 37. Helenius, L.M., Meurman, J.H., Helenius, I., Kari, K., Hietanen, J.,20. De Almeida, D.E., Ling, S., Pi, X., Hartmann-Scruggs, A.M., Suuronen, R., Hallikainen, D., Kautiainen, H., Leirisalo-Repo, M. Pumpens, P. and Holoshitz, J. Immune dysregulation by the rheu- and Lindqvist, C. Oral and salivary parameters inpatients with matoid arthritis shared epitope. J. Immunol. 185: 1927-1934, 2010. rheumatic diseases. Acta Odontol. Scand. 63: 284-293, 2005.21. Deane, K.D., Norris, J.M. and Holers, V.M. Preclinical rheumatoid 38. Heliovaara, M., Aho, K., Aromaa, A., Knekt, P. and Reunanen, A. arthritis: identification, evaluation, and future directions for in- Smoking and risk of rheumatoid arthritis. J. Rheumatol. 20: 1830- vestigation. Rheum. Dis. Clin. North Am. 36: 213-241, 2010. 1835, 1993.22. Duramad, P., Harley, K., Lipsett, M., Bradman, A., Eskenazi, B., 39. Hill, J.A., Southwood, S., Sette, A., Jevnikar, A.M., Bell, D.A. and Holland, N.T. and Tager, I.B. Early environmental exposures and Cairns, E. Cutting edge: the conversion of arginine to citrulline intracellular Th1/Th2 cytokine profiles in 24-month-old children allows for a high-affinity peptide interaction with the rheumatoid living in an agricultural area. Environ. Health Perspect. 114: 1916- arthritis-associated HLA-DRB1*0401 MHC class II molecule. 1922, 2006. J. Immunol. 171: 538-541, 2003.23. Fan, L.Y., Zong, M., Lu, T.B., Yang, L., Ding, Y.Y. and Ma, J.W. 40. Hinks, A., Barton, A., John, S., Bruce, I., Hawkins, C., Griffiths, Association of the PADI4 gene polymorphism and HLA-DRB1 C.E., Donn, R., Thomson, W., Silman, A. and Worthington, J. shared epitope alleles with rheumatoid arthritis. Zhonghua Yi Xue Association between the PTPN22 gene and rheumatoid arthritis Yi Chuan Xue Za Zhi. 26: 57-61, 2009. and juvenile idiopathic arthritis in a UK population: further sup-24. Finnegan, A., Grusby, M.J., Kaplan, C.D., O’Neill, S.K., Eibel, H., port that PTPN22 is an autoimmunity gene. Arthritis Rheum. Koreny, T., Czipri, M., Mikecz, K. and Zhang, J. IL-4 and IL-12 52: 1694-1699, 2005. regulate proteoglycan-induced arthritis through Stat-dependent 41. Hinks, A., Worthington, J. and Thomson, W. The association of mechanisms. J. Immunol. 169: 3345-3352, 2002. PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis.25. Firestein, G.S. Evolving concepts of rheumatoid arthritis. Nature Rheumatology (Oxford) 45: 365-368, 2006. 423: 356-361, 2003. 42. Hollis-Moffatt, J.E., Merriman, M.E., Rodger, R.A., Rowley, K.A.,26. Freudenberg, J., Lee, H.S., Han, B.G., Shin, H.D., Kang, Y.M., Chapman, P.T., Dalbeth, N., Gow, P.J., Harrison, A.A., Highton, J., Sung, Y.K., Shim, S.C., Choi, C.B., Lee, A.T., Gregersen, P.K. and Jones, P.B., O’Donnell, J.L., Stamp, L.K. and Merriman, T.R. Bae, S.C. Genome-wide association study of rheumatoid arthritis Evidence for association of an interleukin 23 receptor variant in Koreans: Population-specific loci as well as overlap with Euro- independent of the R381Q variant with rheumatoid arthritis. Ann. pean susceptibility loci. Arthritis Rheum. 63: 884-893, 2011. Rheum. Dis. 68: 1340-1344, 2009.27. Gandjbakhch, F., Fajardy, I., Ferre, B., Dubucquoi, S., Flipo, R.M., 43. Holoshitz, J. The rheumatoid arthritis HLA-DRB1 shared epitope. Roger, N. and Solau-Gervais, E. A functional haplotype of PADI4 Curr. Opin. Rheumatol. 22: 293-298, 2010. gene in rheumatoid arthritis: positive correlation in a French popu- 44. Holsapple, M.P. Autoimmunity by pesticides: a critical review of lation. J. Rheumatol. 36: 881-886, 2009. the state of the science. Toxicol. Lett. 127: 101-109, 2002.28. Ghoreschi, K., Laurence, A., Yang, X.P., Tato, C.M., McGeachy, 45. Huizinga, T.W., Amos, C.I., van der Helm-van, Mil, A.H., Chen, M.J., Konkel, J.E., Ramos, H.L., Wei, L., Davidson, T.S., Bouladoux, W., van Gaalen, F.A., Jawaheer, D., Schreuder, G.M., Wener, M., N., Grainger, J.R., Chen, Q., Kanno, Y., Watford, W.T., Sun, H.W., Breedveld, F.C., Ahmad, N., Lum, R.F., de Vries, R.R., Gregersen, Eberl, G., Shevach, E.M., Belkaid, Y., Cua, D.J., Chen, W. and P.K., Toes, R.E. and Criswell, L.A. Refining the complex rheuma- O’Shea, J.J. Generation of pathogenic TH17 cells in the absence of toid arthritis phenotype based on specificity of the HLA-DRB1 TGF-β signalling. Nature 467: 967-971, 2010. shared epitope for antibodies to citrullinated proteins. Arthritis29. Gorman, J.D., Lum, R.F., Chen, J.J., Suarez-Almazor, M.E., Rheum. 52: 3433-3438, 2005. Thomson, G. and Criswell, L.A. Impact of shared epitope genotype 46. International Multiple Sclerosis Genetics Consortium (IMSGC). and ethnicity on erosive disease: a meta-analysis of 3,240 rheuma- The expanding genetic overlap between multiple sclerosis and type toid arthritis patients. Arthritis Rheum. 50: 400-412, 2004. I diabetes. Genes Immun. 10: 11-14, 2009.30. Graves, D.T. and Cochran, D. The contribution of interleukin-1 and 47. Iwamoto, T., Ikari, K., Nakamura, T., Kuwahara, M., Toyama, Y., tumor necrosis factor to periodontal tissue destruction. J. Periodontol. Tomatsu, T., Momohara, S. and Kamatani, N. Association between 74: 391-401, 2003. PADI4 and rheumatoid arthritis: a meta-analysis. Rheumatology
  10. 10. 82 Tan, Hung and Tsao (Oxford). 45: 804-807, 2006. in FCRL3, encoding Fc receptor-like 3, is associated with rheuma-48. Jawaheer, D., Seldin, M.F., Amos, C.I., Chen, W.V., Shigeta, R., toid arthritis and several autoimmunities. Nat. Genet. 37: 478-485, Monteiro, J., Monteiro, J., Kern, M., Criswell, L.A., Albani, S., 2005. Nelson, J.L., Clegg, D.O., Pope, R., Schroeder, H.W. Jr., Bridges, 60. Korman, B.D., Kastner, D.L., Gregersen, P.K. and Remmers, E.F. S.L. Jr., Pisetsky, D.S., Ward, R., Kastner, D.L., Wilder, R.L., STAT4: genetics, mechanisms, and implications for autoimmunity. Pincus, T., Callahan, L.F., Flemming, D., Wener, M.H. and Curr. Allergy Asthma Rep. 8: 398-403, 2008. Gregersen, P.K. A genomewide screen in multiplex rheumatoid 61. Kurreeman, F.A.S., Padyukov, L., Marques, R.B., Schrodi, S.J., arthritis families suggests genetic overlap with other autoimmune Seddighzadeh, M., Stoeken-Rijsbergen, G., van der Helm-van Mil, diseases. Am. J. Hum. Genet. 68: 927-936, 2001. A.H.M., Allaart, C.F., Verduyn, W., Houwing-Duistermaat, J.,49. Julia, A., Ballina, J., Canete, J.D., Balsa, A., Tornero-Molina, J., Alfredsson, L., Begovich, A.B., Klareskog, L., Huizinga, T.W.J. Naranjo, A., Naranjo, A., Alperi-López, M., Erra, A., Pascual- and Toes, R.E.M. A candidate gene approach identifies the Salcedo, D., Barceló, P., Camps, J. and Marsal, S. Genome-wide TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS association study of rheumatoid arthritis in the Spanish popula- Med. 4: e278, 2007. tion: KLF12 as a risk locus for rheumatoid arthritis susceptibility. 62. Kuru, B., McCullough, M.J., Yilmaz, S. and Porter, S.R. Clinical Arthritis Rheum. 58: 2275-2286, 2008. and microbiological studies of periodontal disease in Sjogren syn-50. Kallberg, H., Padyukov, L., Plenge, R.M., Ronnelid, J., Gregersen, drome patients. J. Clin. Periodontol. 29: 92-102, 2002. P.K., van der Helm-van Mil, A.H., Toes, R.E., Huizinga, T.W., 63. Langrish, C.L., Chen, Y., Blumenschein, W.M., Mattson, J., Basham, Klareskog, L. and Alfredsson, L. Epidemiological Investigation of B., Sedgwick, J.D., McClanahan, T., Kastelein, R.A. and Cua, D.J. Rheumatoid Arthritis study group. Gene-gene and gene-environ- IL-23 drives a pathogenic T cell population that induces autoim- ment interactions involving HLA-DRB1, PTPN22, and smoking in mune inflammation. J. Exp. Med. 201: 233-240, 2005. two subsets of rheumatoid arthritis. Am. J. Hum. Genet. 80: 867- 64. Lee, H.S., Irigoyen, P., Kern, M., Lee, A., Batliwalla, F., Khalili, H., 875, 2007. Wolfe, F., Lum, R.F., Massarotti, E., Weisman, M., Bombardier, C.,51. Kang, C.P., Lee, H.S., Ju, H., Cho, H., Kang, C. and Bae, S.C. A Karlson, E.W., Criswell, L.A., Vlietinck, R. and Gregersen, P.K. functional haplotype of the PADI4 gene associated with increased Interaction between smoking, the shared epitope, and anti-cyclic rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum. citrullinated peptide: a mixed picture in three large North American 54: 90-96, 2006. rheumatoid arthritis cohorts. Arthritis Rheum. 56: 1745-1753,52. Karlson, E.W., Chang, S.C., Cui, J., Chibnik, L.B., Fraser, P.A., De 2007. Vivo, I. and Costenbader, K.H. Gene-environment interaction 65. Lee, H.S., Korman, B.D., Le, J.M., Kastner, D.L., Remmers, E.F., between HLA-DRB1 shared epitope and heavy cigarette smoking Gregersen, P.K. and Bae, S.C. Genetic risk factors for rheumatoid in predicting incident rheumatoid arthritis. Ann. Rheum. Dis. 69: arthritis differ in Caucasian and Korean populations. Arthritis 54-60, 2010. Rheum. 60: 364-371, 2009.53. Kawai, T., Matsuyama, T., Hosokawa, Y., Makihira, S., Seki, M., 66. Liao, F., Li, Z., Wang, Y., Shi, B., Gong, Z. and Cheng, X. Porphy- Karimbux, N.Y., Goncalves, R.B., Valverde, P., Dibart, S., Li, romonas gingivalis may play an important role in the pathogenesis Y.P., Miranda, L.A., Ernst, C.W., Izumi, Y. and Taubman, M.A. of periodontitis-associated rheumatoid arthritis. Med. Hypotheses B and T lymphocytes are the primary sources of RANKL in the 72: 732-735, 2009. bone resorptive lesion of periodontal disease. Am. J. Pathol. 169: 67. Lopez-Arbesu, R., Ballina-Garcia, F.J., Alperi-Lopez, M., Lopez- 987-998, 2006. Soto, A., Rodriguez-Rodero, S., Martinez-Borra, J., López-Vázquez,54. Kilding, R. and Wilson, A.G. Mapping of a novel susceptibility A., Fernández-Morera, J.L., Riestra-Noriega, J.L., Queiro-Silva, gene for rheumatoid arthritis in the telomeric MHC region. Cytokine R., Qui˜ ones-Lombra˜ a, A., López-Larrea, C. and González, S. n n 32: 71-75, 2005. MHC class I chain-related gene B (MICB) is associated with rheu-55. Kim, H.P., Imbert, J. and Leonard, W.J. Both integrated and matoid arthritis susceptibility. Rheumatology 46: 426-430, 2007. differential regulation of components of the IL-2/IL-2 receptor 68. Lu, H.K., Chen, Y.L., Chang, H.C., Li, C.L. and Kuo, M.Y. Iden- system. Cytokine Growth Factor Rev. 17: 349-366, 2006. tification of the osteoprotegerin/receptor activator of nuclear fac-56. Kirsten, H., Petit-Teixeira, E., Scholz, M., Hasenclever, D., tor-κB ligand system in gingival crevicular fluid and tissue of Hantmann, H., Heider, D., Heider, D., Wagner, U., Sack, U., Hugo patients with chronic periodontitis. J. Peridontol. Res. 41: 354-360, Teixeira, V., Prum, B., Burkhardt, J., Pierlot, C., Emmrich, F., 2006. Cornelis, F. and Ahnert, P. Association of MICA with rheumatoid 69. Luebke, R.W., Parks, C. and Luster, M.I. Suppression of immune arthritis independent of known HLA-DRB1 risk alleles in a family- function and susceptibility to infections in humans: association of based and a case control study. Arthritis Res. Ther. 11: R60, 2009. immune function with clinical disease. J. Immunotoxicol. 1: 15-24,57. Klareskog, L., Stolt, P., Lundberg, K., Kallberg, H., Bengtsson, C., 2004. Grunewald, J., Rönnelid, J., Harris, H.E., Ulfgren, A.K., Rantapää- 70. MacGregor, A.J., Snieder, H., Rigby, A.S., Koskenvuo, M., Kaprio, Dahlqvist, S., Eklund, A., Padyukov, L. and Alfredsson, L. A new J., Aho, K. and Silman, A.J. Characterizing the quantitative genetic model for an etiology of rheumatoid arthritis: smoking may trigger contribution to rheumatoid arthritis using data from twins. Arthritis HLA-DR (shared epitope)-restricted immune reactions to autoan- Rheum. 43: 30-37, 2000. tigens modified by citrullination. Arthritis Rheum. 54: 38-46, 2006. 71. Mahdi, H., Fisher, B.A., Kallberg, H., Plant, D., Malmstrom, V.,58. Kochi, Y., Okada, Y., Suzuki, A., Ikari, K., Terao, C., Takahashi, Ronnelid, J., Charles, P., Ding, B., Alfredsson, L., Padyukov, L., A., Yamazaki, K., Hosono, N., Myouzen, K., Tsunoda, T., Kamatani, Symmons, D.P., Venables, P.J., Klareskog, L. and Lundberg, K. N., Furuichi, T., Ikegawa, S., Ohmura, K., Mimori, T., Matsuda, F., Specific interaction between genotype, smoking and autoimmunity Iwamoto, T., Momohara, S., Yamanaka, H., Yamada, R., Kubo, M., to citrullinated α-enolase in the etiology of rheumatoid arthritis. Nakamura, Y. and Yamamoto, K. A regulatory variant in CCR6 Nat. Genet. 41: 1319-1324, 2009. is associated with rheumatoid arthritis susceptibility. Nat. Genet. 72. Martinez-Martinez, R.E., Abud-Mendoza, C., Patino-Marin, N., 42: 515-519, 2010. Rizo-Rodríguez, J.C., Little, J.W. and Loyola-Rodríguez, J.P.59. Kochi, Y., Yamada, R., Suzuki, A., Harley, J.B., Shirasawa, S., Detection of periodontal bacterial DNA in serum and synovial fluid Sawada, T., Bae, S.C., Tokuhiro, S., Chang, X., Sekine, A., in refractory rheumatoid arthritis patients. J. Clin. Periodontol. Takahashi, A., Tsunoda, T., Ohnishi, Y., Kaufman, K.M., Kang, 36: 1004-1010, 2009. C.P., Kang, C., Otsubo, S., Yumura, W., Mimori, A., Koike, T., 73. Mathur, A.N., Chang, H.C., Zisoulis, D.G., Stritesky, G.L., Yu, Q., Nakamura, Y., Sasazuki, T. and Yamamoto, K. A functional variant O’Malley, J.T., Kapur, R., Levy, D.E., Kansas, G.S. and Kaplan,
  11. 11. Genetic and Environmental Risk Factors in Rheumatoid Arthritis 83 M.H. Stat3 and Stat4 direct development of IL-17-secreting Th polymorphisms and rheumatoid arthritis susceptibility. Rheumatol. cells. J. Immunol. 178: 4901-4907, 2007. Int. 29: 781-786, 2009.74. Mercado, F.B., Marshall, R.I. and Bartold, P.M. Inter-relationships 91. Parks, C.G., Walitt, B.T., Pettinger, M., Chen, J.C., de Roos, A.J., between rheumatoid arthritis and periodontal disease. J. Clin. Hunt, J., Sarto, G. and Howard, B.V. Insecticide use and risk of Periodontol. 30: 761-772, 2003. rheumatoid arthritis and systemic lupus erythematosus in the75. Mok, J.W., Lee, Y.J., Kim, J.Y., Lee, E.B., Song, Y.W., Park, M.H. Women’s Health Initiative Observational Study. Arthritis Care and Park, K.S. Association of MICA polymorphism with rheuma- Res. 63: 184-194, 2011. toid arthritis patients in Koreans. Hum. Immunol. 64: 1190-1194, 92. Pers, J.O., d’Arbonneau, F., Devauchelle-Pensec, V., Saraux, A., 2003. Pennec, Y.L. and Youinou, P. Is periodontal disease mediated76. Munroe, M.E. and Bishop, G.A. A costimulatory function for T by salivary BAFF in Sjögren’s syndrome? Arthritis Rheum. 52: cell CD40. J. Immunol. 178: 671-682, 2007. 2411-2414, 2005.77. Musone, S.L., Taylor, K.E., Nititham, J., Chu, C., Poon, A., Liao, 93. Pischon, N., Pischon, T., Kröger, J., Gülmez, E., Kleber, B.M., W., Lam, E.T., Ma, A., Kwok, P.Y. and Criswell, L.A. Sequencing Bernimoulin, J.P., Landau, H., Brinkmann, P.G., Schlattmann, P., of TNFAIP3 and association of variants with multiple autoimmune Zernicke, J., Buttgereit, F. and Detert, J. Association among diseases. Genes Immun. 12: 176-182, 2011. rheumatoid arthritis, oral hygiene, and periodontitis. J. Periodontol.78. Nakae, S., Nambu, A., Sudo, K. and Iwakura, Y. Suppression of 79: 979-786, 2008. immune induction of collagen-induced arthritis in IL-17-deficient 94. Plenge, R.M. Shared genetic risk factors for type 1 diabetes and mice. J. Immunol. 171: 6173-6177, 2003. celiac disease. N. Engl. J. Med. 359: 2837-2838, 2008.79. Nesse, W., Dijkstra, P.U., Abbas, F., Spijkervet, F.K., Stijger, A., 95. Plenge, R.M., Cotsapas, C., Davies, L., Price, A.L., de Bakker, P.I., Tromp, J.A. van Dijk, J.L. and Vissink, A. Increased prevalence of Maller, J., Pe’er, I., Burtt, N.P., Blumenstiel, B., DeFelice, M., cardiovascular and autoimmune diseases in periodontitis patients: Parkin, M., Barry, R., Winslow, W., Healy, C., Graham, R.R., a cross-sectional study. J. Periodontol. 81: 1622-1628, 2010. Neale, B.M., Izmailova, E., Roubenoff, R., Parker, A.N., Glass, R.,80. Nesse, W., Westra, J., van der Wal, J.E., Balsma, J., Abbas, F., Karlson, E.W., Maher, N., Hafler, D.A., Lee, D.M., Seldin, M.F., Brouwer, E. and Vissink, A. The periodontium contains citrulli- Remmers, E.F., Lee, A.T., Padyukov, L., Alfredsson, L., Coblyn, J., nated proteins, PAD-2 enzymes and HC gp-39. Arthritis Rheum. Weinblatt, M.E., Gabriel, S.B., Purcell, S., Klareskog, L., Gregersen, 60: S434-S435, 2009. P.K., Shadick, N.A., Daly, M.J. and Altshuler, D. Two indepen-81. Newton, J.L., Harney, S.M., Wordsworth, B.P. and Brown, M.A. dent alleles at 6q23 associated with risk of rheumatoid arthritis. A review of the MHC genetics of rheumatoid arthritis. Genes Nat. Genet. 39: 1477-1482, 2007. Immun. 5: 151-157, 2004. 96. Plenge, R.M., Padyukov, L., Remmers, E.F., Purcell, S., Lee, A.T.,82. Nishikomori, R., Usui, T., Wu, C.Y., Morinobu, A., O’Shea, J.J. Karlson, E.W., Wolfe, F., Kastner, D.L., Alfredsson, L., Altshuler, and Strober, W. Activated STAT4 has an essential role in Th1 dif- D., Gregersen, P.K., Klareskog, L. and Rioux, J.D. Replication ferentiation and proliferation that is independent of its role in of putative candidate-gene associations with rheumatoid arthritis the maintenance of IL-12Rβ2 chain expression and signaling. in >4,000 samples from North America and Sweden: association J. Immunol. 169: 4388-4398, 2002. of susceptibility with PTPN22, CTLA4, and PADI4. Am. J. Hum.83. Olsson, A.R., Skogh, T., Axelson, O. and Wingren, G. Occupations Genet. 77: 1044-1060, 2005. and exposures in the work environment as determinants for rheuma- 97. Plenge, R.M., Seielstad, M., Padyukov, L., Lee, A.T., Remmers, toid arthritis. Occup. Environ. Med. 61: 233-238, 2004. E.F., Ding, B., Liew, A., Khalili, H., Chandrasekaran, A., Davies,84. Olsson, A.R., Skogh, T. and Wingren, G. Occupational deter- L.R., Li, W., Tan, A.K., Bonnard, C., Ong, R.T., Thalamuthu, A., minants for rheumatoid arthritis Scand. J. Work Environ. Health Pettersson, S., Liu, C., Tian, C., Chen, W.V., Carulli, J.P., Beckman, 26: 243-249, 2000. E.M., Altshuler, D., Alfredsson, L., Criswell, L.A., Amos, C.I.,85. Orozco, G., Eyre, S., Hinks, A., Bowes, J., Morgan, A.W., Wilson, Seldin, M.F., Kastner, D.L., Klareskog, L. and Gregersen, P.K. A.G., Wordsworth, P., Steer, S., Hocking, L., UKRAG consortium, TRAF1-C5 as a risk locus for rheumatoid arthritis—a genomewide Thomson, W., Worthington, J. and Barton, A. Study of the common study. N. Engl. J. Med. 357: 1199-1209, 2007. genetic background for rheumatoid arthritis and systemic lupus 98. Raychaudhuri, S., Remmers, E.F., Lee, A.T., Hackett, R., Guiducci, erythematosus. Ann. Rheum. Dis. 70: 463-468, 2011. C., Guiducci, C., Burtt, N.P., Gianniny, L., Korman, B.D., Padyukov,86. Orozco, G., Hinks, A., Eyre, S., Ke, X., Gibbons, L.J., Bowes, J., L., Kurreeman, F.A., Chang, M., Catanese, J.J., Ding, B., Wong, S., Flynn, E., Martin, P., Wellcome Trust Case Control Consortium, van der Helm-van Mil, A.H., Neale, B.M., Coblyn, J., Cui, J., Tak, YEAR consortium, Wilson, A.G., Bax, D.E., Morgan, A.W., Emery, P.P., Wolbink, G.J., Crusius, J.B., van der Horst-Bruinsma, I.E., P., Steer, S., Hocking, L., Reid, D.M., Wordsworth, P., Harrison, P., Criswell, L.A., Amos, C.I., Seldin, M.F., Kastner, D.L., Ardlie, Thomson, W., Barton, A. and Worthington, J. Combined effects of K.G., Alfredsson, L., Costenbader, K.H., Altshuler, D., Huizinga, three independent SNPs greatly increase the risk estimate for RA T.W., Shadick, N.A., Weinblatt, M.E., de Vries, N., Worthington, at 6q23. Hum. Mol. Genet. 18: 2693-2699, 2009. J., Seielstad, M., Toes, R.E., Karlson, E.W., Begovich, A.B.,87. Padyukov, L., Seielstad, M., Ong, R.T., Ding, B., Ronnelid, J., Klareskog, L., Gregersen, P.K., Daly, M.J. and Plenge, R.M. Seddighzadeh, M., Alfredsson, L., Klareskog, L. and the Epidemio- Common variants at CD40 and other loci confer risk of rheumatoid logical Investigation of Rheumatoid Arthritis (EIRA) study group. arthritis. Nat. Genet. 40: 1216-1223, 2008. Genome-wide association study suggests contrasting associations 99. Raychaudhuri, S., Thomson, B.P., Remmers, E.F., Eyre, S., Hinks, in ACPA-positive versus ACPA-negative rheumatoid arthritis. A., Guiducci, C., Catanese, J.J., Xie, G., Stahl, E.A., Chen, R., Ann.Rheum. Dis. 70: 259-265, 2011. Alfredsson, L., Amos, C.I., Ardlie, K.G., BIRAC Consortium,88. Padyukov, L., Silva, C., Stolt, P., Alfredsson, L. and Klareskog, L. Barton, A., Bowes, J., Burtt, N.P., Chang, M., Coblyn, J., A gene-environment interaction between smoking and shared epitope Costenbader, K.H., Criswell, L.A., Crusius, J.B., Cui, J., De Jager, genes in HLA-DR provides a high risk of seropositive rheumatoid P.L., Ding, B., Emery, P., Flynn, E., Harrison, P., Hocking, L.J., arthritis. Arthritis Rheum. 50: 3085-3092, 2004. Huizinga, T.W., Kastner, D.L., Ke, X., Kurreeman, F.A., Lee, A.T.,89. Paradowska-Gorycka, A., Grzybowska-Kowalczyk, A., Wojtecka- Liu, X., Li, Y., Martin, P., Morgan, A.W., Padyukov, L., Reid, Lukasik, E. and Maslinski, S. IL-23 in the pathogenesis of rheuma- D.M., Seielstad, M., Seldin, M.F., Shadick, N.A., Steer, S., Tak, toid arthritis. Scand. J. Immunol. 71: 134-145, 2010. P.P., Thomson, W., van der Helm-van Mil, A.H., van der Horst-90. Park, J.H., Kim, Y.J., Park, B.L., Bae, J.S., Shin, H.D. and Bae, Bruinsma, I.E., Weinblatt, M.E., Wilson, A.G., Wolbink, G.J., S.C. Lack of association between interleukin 23 receptor gene Wordsworth, P., YEAR Consortium, Altshuler, D., Karlson, E.W.,
  12. 12. 84 Tan, Hung and Tsao Toes, R.E., de Vries, N., Begovich, A.B., Siminovitch, K.A., Reid, D.M., Wordsworth, P., Harrison, P., Strachan, D. and Worthington, J., Klareskog, L., Gregersen, P.K., Daly, M.J. and Worthington, J. Rheumatoid arthritis association at 6q23. Nat. Plenge, R.M. Genetic variants at CD28, PRDM1 and CD2/CD58 Genet. 39: 1431-1433, 2007. are associated with rheumatoid arthritis risk. Nat. Genet. 41: 110. Wara-aswapati, N., Surarit, R., Chayasadom, A., Boch, J.A. and 1313-1318, 2009. Pitiphat, W. RANKL upregulation associated with periodontitis100. Remmers, E.F., Plenge, R.M., Lee, A.T., Graham, R.R., Hom, G., and Porphyromonas gingivalis. J. Periodontol. 78: 1062-1069, Behrens, T.W., de Bakker, P.I., Le, J.M., Lee, H.S., Batliwalla, F., 2007. Li, W., Masters, S.L., Booty, M.G., Carulli, J.P., Padyukov, L., 111. Wegner, N., Wait, R., Sroka, A., Eick, S., Nguyen, K.A., Lundberg, Alfredsson, L., Klareskog, L., Chen, W.V., Amos, C.I., Criswell, K., Kinloch, A., Culshaw, S., Potempa, J. and Venables, P.J. L.A., Seldin M.F., Kastner, D.L. and Gregersen, P.K. STAT4 and Peptidylarginine deiminase from Porphyromonas gingivalis the risk of rheumatoid arthritis and systemic lupus erythematosus. citrullinates human fibrinogen and α-enolase: implications for N. Engl. J. Med. 357: 977-986, 2007. autoimmunity in rheumatoid arthritis. Arthritis Rheum. 62: 2662-101. Smolen, J.S., Aletaha, D., Koeller, M., Weisman, M.H. and 2672, 2010. Emery, P. New therapies for treatment of rheumatoid arthritis. 112. Weissmann, G. Pathogenesis of rheumatoid arthritis. J. Clin. Lancet 370: 1861-1874, 2007. Rheumatol. 10: S26-S31, 2004.102. Stahl, E.A., Raychaudhuri, S., Remmers, E.F., Xie, G., Eyre, S., 113. Wellcome Trust Case Control Consortium. Genome-wide asso- Thomson, B.P., Li, Y., Kurreeman, F.A., Zhernakova, A., Hinks, ciation study of 14,000 cases of seven common diseases and 3,000 A., Guiducci, C., Chen, R., Alfredsson, L., Amos, C.I., Ardlie, shared controls. Nature 447: 661-678, 2007. K.G., BIRAC Consortium, Barton, A., Bowes, J., Brouwer, E., 114. Uddin, M., Sturge, M., Rahman, P. and Woods, M.O. Autosome- Burtt, N.P., Catanese, J.J., Coblyn, J., Coenen, M.J., Costenbader, wide copy number variation association analysis for rheumatoid K.H., Criswell, L.A., Crusius, J.B., Cui, J., de Bakker, P.I., De arthritis using the WTCCC high-density SNP genotype data. Jager, P.L., Ding, B., Emery, P., Flynn, E., Harrison, P., Hocking, J. Rheumatol. 38: 797-801, 2011. L.J., Huizinga, T.W., Kastner, D.L., Ke, X., Lee, A.T., Liu, X., 115. van den Berg, W.B. and Miossec, P. IL-17 as a future therapeutic Martin, P., Morgan, A.W., Padyukov, L., Posthumus, M.D., target for rheumatoid arthritis. Nat. Rev. Rheumatol. 5: 549-553, Radstake, T.R., Reid, D.M., Seielstad, M., Seldin, M.F., Shadick, 2009. N.A., Steer, S., Tak, P.P., Thomson, W., van der Helm-van Mil, 116. van der Linden, M.P., Feitsma, A.L., le C.S., Kern, M., Olsson, A.H., van der Horst-Bruinsma, I.E., van der Schoot, C.E., van Riel, L.M., Raychaudhuri, S., Begovich, A.B., Chang, M., Catanese, P.L., Weinblatt, M.E., Wilson, A.G., Wolbink, G.J., Wordsworth, J.J., Kurreeman, F.A., van Nies, J. and van der Heijde, D.M., B.P.,YEAR Consortium, Wijmenga, C., Karlson, E.W., Toes, Gregersen, P.K., Huizinga, T.W., Toes, R.E. van der Helm-Van R.E., de Vries, N., Begovich, A.B., Worthington, J., Siminovitch, Mil, A.H. Association of a single-nucleotide polymorphism in K.A., Gregersen, P.K., Klareskog, L. and Plenge, R.M. Genome- CD40 with the rate of joint destruction in rheumatoid arthritis. wide association study meta-analysis identifies seven new rheu- Arthritis Rheum. 60: 2242-2247, 2009. matoid arthritis risk loci. Nat. Genet. 42: 508-514, 2010. 117. van Gaalen, F.A., van Aken, J., Huizinga, T.W., Schreuder, G.M.,103. Stastny, P. Association of the B-cell alloantigen DRw4 with Breedveld, F.C., Zanelli, E., van Venrooij, W.J., Verweij, C.L., rheumatoid arthritis. N. Engl. J. Med. 298: 869-871, 1978. Toes, R.E. and de Vries, R.R. Association between HLA class II104. Suzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., genes and autoantibodies to cyclic citrullinated peptides (CCPs) Suzuki, M. Nagasaki, M., Nakayama-Hamada, M., Kawaida, R., influences the severity of rheumatoid arthritis. Arthritis Rheum. Ono, M., Ohtsuki, M., Furukawa, H., Yoshino, S., Yukioka, M., 50: 2113-2121, 2004. Tohma, S., Matsubara, T., Wakitani, S., Teshima, R., Nishioka, 118. Varade, J., Ramon Lamas, J., Rodriguez, L., Fernandez-Arquero, Y., Sekine, A., Iida, A., Takahashi, A., Tsunoda, T., Nakamura, Y. M., Loza-Santamaria, E., Jover, J.A., de la Concha, E.G., Fernandez- and Yamamoto, K. Functional haplotypes of PADI4, encoding Gutierrez, B., Urcelay, E. and Martinez, A. IL23R and IL12B citrullinating enzyme peptidylarginine deiminase 4, are associ- genes: susceptibility analysis in rheumatoid. Ann. Rheum. Dis. ated with rheumatoid arthritis. Nat. Genet. 34: 395-402, 2003. 68: 1230-1232, 2009.105. Suzuki, A., Yamada, R., Kochi, Y., Sawada, T., Okada, Y., 119. Vernal, R., Dutzanm N., Chaparro, A., Puente, J., Antonieta Matsuda, K., Kamatani, Y., Mori, M., Shimane, K., Hirabayashi, Valenzuela, M. and Gamonal, J. Levels of interleukin-17 in gin- Y., Takahashi, A., Tsunoda, T., Miyatake, A., Kubo, M., Kamatani, gival crevicular fluid and in supernatants of cellular cultures of N., Nakamura, Y. and Yamamoto, K. Functional SNPs in CD244 gingival tissue from patients with chronic periodontitis. J. Clin. increase the risk of rheumatoid arthritis in a Japanese population. Periodontol. 32: 383-389, 2005. Nat. Genet. 40: 1224-1229, 2008. 120. Zhernakova, A., Alizadeh, B.Z., Bevova, M., van Leeuwen, M.A.,106. Szodoray, P., Szabo, Z., Kapitany, A., Gyetvai, A., Lakos, G., Coenen, M.J., Franke, B., Franke, L., Posthumus, M.D., van Heel, Szanto, S., Szücs, G. and Szekanecza, Z. Anti-citrullinated D.A., van der Steege, G., Radstake, T.R., Barrera, P., Roep, B.O., protein/peptide autoantibodies in association with genetic and Koeleman, B.P. and Wijmenga, C. Novel association in chromo- environmental factors as indicators of disease outcome in rheuma- some 4q27 region with rheumatoid arthritis and confirmation toid arthritis. Autoimmun. Rev. 9: 140-143, 2010. of type 1 diabetes point to a general risk locus for autoimmune107. Taubman, M.A., Valverde, P., Han, X. and Kawai, T. Immune diseases. Am. J. Hum. Genet. 81: 1284-1288, 2007. response: the key to bone resorption in periodontal disease. J. 121. Zhernakova, A., Stahl, E.A., Trynka, G., Raychaudhuri, S., Festen, Periodontol. 76: 2033-2041, 2005. E.A., Franke, L., Westra, H.J., Fehrmann, R.S., Kurreeman, F.A.,108. Thabet, M.M., Huizinga, T.W., Marques, R.B., Stoeken-Rijsbergen, Thomson, B., Gupta, N., Romanos, J., McManus, R., Ryan, A.W., G., Bakker, A.M., Kurreeman, F.A., White, S.J., Toes, R.E.M. and Turner, G., Brouwer, E., Posthumus, M.D., Remmers, E.F., Tucci, van der Helm-van Mil, A.H.M. Contribution of Fcγ receptor IIIA F., Toes, R., Grandone, E., Mazzilli, M.C., Rybak, A., Cukrowska, gene 158V/F polymorphism and copy number variation to the risk B., Coenen, M.J., Radstake, T.R., van Riel, P.L., Li, Y., de Bakker, of ACPA-positive rheumatoid arthritis. Ann. Rheum. Dis. 68: P.I., Gregersen, P.K., Worthington, J., Siminovitch, K.A., 1775-1780, 2009. Klareskog, L., Huizinga, T.W., Wijmenga, C. and Plenge, R.M.109. Thomson, W., Barton, A., Ke, X., Eyre, S., Hinks, A., Bowes, J., Meta-Analysis of genome-wide association studies in celiac dis- Donn, R., Symmons, D., Hider, S., Bruce, I.N., Wellcome Trust ease and rheumatoid arthritis identifies fourteen non-HLA shared Case Control Consortium, Wilson, A.G., Marinou, I., Morgan, A., loci. PLoS Genet. 7: e1002004, 2011. Emery, P. YEAR Consortium, Carter, A., Steer, S., Hocking, L.,